Search Results - "Steen, PD"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial by Parrino, Janie, Popmihajlov, Zoran, Annunziato, Paula W, Fein, L, Singh, M, Morrissey, O, Kuehr, T, Duck, L, De Prijck, B, Serrano, SV, Camargo, JFC, Radinov, A, Minchev, V, Grimard, D, Weiss, K, Diaz-Mitoma, FJ, Torres Ulloa, R, Fardella, P, Gonzalez, P, Gonzalez, ME, Rojas, CA, Paulson, G, Ontaneda, M, Laine, F, Laurichesse, H, Duval, X, Cornely, OA, Zaiss, M, Verbeek, M, Georgoulias, V, Terpos, E, Umanzor, J, Bejarano, S, Gentile, G, Rambaldi, A, Marei, L, Abbadi, A, Kattan, J, Blacklock, H, Tiangco, BJ, Cabanillas, F, Ciuleanu, TE, Cainap, CI, Dvorkin, MV, Litvinov, IV, Goh, YT, Matejkova, M, Reckova, M, Yoon, SS, Duran Martinez, I, Chen, C-Y, Sriuranpong, V, Akan, H, Mullan, SR, Sivarajan, K, Marquez, F, Mullane, MR, Mazurczak, MA, Zenk, D, Robinson, MO, Naqvi, T, Ahmed, M, Badarinath, S, Kendall, SD, Chedid, S, Rafiyath, S, Buechler-Price, J, Sreenivasappa, S, Geller, R, Nieva, J, Wong, BMY, Ibrahim, EN, Oliff, IA, Guter, KA, Rao, SB, Columbie, A, Nualart, MT, Campos, LT, Sharma, S, Ortiz, T, Markowitz, AB, Koo, VS, Murray, C, Gurtler, JS, Ascensao, JL, Santander, JL, Garg, RJ, Lowry, P, Baker, J, Roeland, E, Payne, JE, Betts, RF, Sharp, SA, Congdon, J, Wos, EJ, Hutchins, M, Chowhan, NM, O'Rourke, TJ, Winkler, CF, Duic, JP

    Published in The Lancet infectious diseases (01-09-2019)
    “…Patients who are immunocompromised because of malignancy have an increased risk of herpes zoster and herpes zoster-related complications. We aimed to…”
    Get full text
    Journal Article
  2. 2

    Opioid-induced muscle activity: implications for managing chronic pain by Sylvester, R K, Levitt, R, Steen, P D

    Published in The Annals of pharmacotherapy (01-11-1995)
    “…To increase awareness of opioid-induced involuntary muscle hyperactivity and to present management options. A ventilator-dependent 71-year-old man presented…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy by Loprinzi, C L, Ghosh, C, Camoriano, J, Sloan, J, Steen, P D, Michalak, J C, Schaefer, P L, Novotny, P J, Gerstner, J B, White, D F, Hatfield, A K, Quella, S K

    Published in Journal of clinical oncology (01-03-1997)
    “…Stomatitis is a major dose-limiting toxicity of bolus fluorouracil (5FU)-based chemotherapy regimens, despite the use of oral cryotherapy. Pursuant to…”
    Get more information
    Journal Article
  6. 6

    False elevation of CA 19-9 levels in a patient with a history of pancreatic cancer by Goetz, M, Steen, P D

    Published in The American journal of gastroenterology (01-08-1997)
    “…CA 19-9 is the most sensitive and specific marker currently used in the diagnosis of pancreatic cancer. Its interpretation, however, can be limited in the…”
    Get more information
    Journal Article
  7. 7

    Granulocyte-Macrophage Colony-Stimulating Factor Treatment Before Doxorubicin and Cyclophosphamide Chemotherapy Priming in Women With Early-Stage Breast Cancer by KOBRINSKY, N. L, SJOLANDER, D. E, CHEANG, M. S, LEVITT, R, STEEN, P. D

    Published in Journal of clinical oncology (01-11-1999)
    “…To determine if inhibition of stem-cell activity induced by granulocyte-macrophage colony-stimulating factor ([GM-CSF]; Sargramostim; Immunex Corporation,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure by Steen, PD, McGregor, JR, Lehman, CM, Samlowski, WE

    Published in The Journal of immunology (1950) (15-12-1989)
    “…The effects of IL-2 on the expression of homing receptors by lymphocytes of NK or lymphokine activated killer (LAK) cell derivation has not yet been evaluated…”
    Get full text
    Journal Article